• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病住院加重和死亡的预测因素
PLoS One. 2016 Jun 30;11(6):e0158727. doi: 10.1371/journal.pone.0158727. eCollection 2016.
2
In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.首次因慢性阻塞性肺疾病急性加重住院患者的院内及一年死亡率及其预测因素:一项基于全国人口的研究。
PLoS One. 2014 Dec 9;9(12):e114866. doi: 10.1371/journal.pone.0114866. eCollection 2014.
3
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的炎症生物标志物与加重。
JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.
4
Prevalence of Influenza Vaccination in Chronic Obstructive Pulmonary Disease Patients and Impact on the Risk of Severe Exacerbations.慢性阻塞性肺疾病患者流感疫苗接种率及其对严重急性加重风险的影响
Arch Bronconeumol. 2016 Feb;52(2):88-95. doi: 10.1016/j.arbres.2015.09.001. Epub 2015 Oct 29.
5
Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study.既往加重频率和疾病严重程度对 COPD 未来加重风险的独立影响:一项回顾性队列研究。
NPJ Prim Care Respir Med. 2016 Sep 8;26:16046. doi: 10.1038/npjpcrm.2016.46.
6
Determining prognosis in acute exacerbation of COPD.慢性阻塞性肺疾病急性加重期的预后判定
Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:467-475. doi: 10.2147/COPD.S122382. eCollection 2017.
7
Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.慢性阻塞性肺疾病(COPD)严重加重和死亡率的预测:加重病史及吸气容量/肺总量比值的作用
Int J Chron Obstruct Pulmon Dis. 2018 Apr 5;13:1105-1113. doi: 10.2147/COPD.S155848. eCollection 2018.
8
Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.慢性阻塞性肺疾病全球倡议2013分类与体重指数、气流阻塞、呼吸困难和加重指数在预测老年慢性阻塞性肺疾病患者死亡率和病情加重方面的比较
J Am Geriatr Soc. 2015 Feb;63(2):244-50. doi: 10.1111/jgs.13258. Epub 2015 Feb 2.
9
The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.在瑞典二级医疗机构就诊的重度慢性阻塞性肺疾病(COPD)患者中,同时患有慢性支气管炎和频繁急性加重的表型。
Int J Chron Obstruct Pulmon Dis. 2015 Oct 28;10:2327-34. doi: 10.2147/COPD.S91362. eCollection 2015.
10
Impact of mild exacerbation on COPD symptoms in a Japanese cohort.轻度加重对日本队列中慢性阻塞性肺疾病(COPD)症状的影响。
Int J Chron Obstruct Pulmon Dis. 2016 Jun 9;11:1269-78. doi: 10.2147/COPD.S105454. eCollection 2016.

引用本文的文献

1
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.慢性阻塞性肺疾病与英国心肺风险的管理:一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
2
Clinical and Paraclinical Characteristics and Predictive Factors of Chronic Obstructive Pulmonary Exacerbation.慢性阻塞性肺疾病急性加重的临床及辅助检查特征与预测因素
Mater Sociomed. 2025;37(1):32-36. doi: 10.5455/msm.2025.37.32-36.
3
Evaluation of the effectiveness of medroxyprogesterone on blood gases and short-term hospital outcomes in patients with chronic obstructive pulmonary disease treating with noninvasive ventilation: A randomized clinical trial.甲羟孕酮对慢性阻塞性肺疾病无创通气治疗患者血气及短期住院结局的有效性评估:一项随机临床试验。
J Res Med Sci. 2024 Nov 28;29:72. doi: 10.4103/jrms.jrms_198_24. eCollection 2024.
4
Use of complementary and alternative medicine among females with polycystic ovary syndrome in Jordan: a cross-sectional study.约旦多囊卵巢综合征女性中补充和替代医学的使用:一项横断面研究。
BMJ Open. 2024 Dec 23;14(12):e088945. doi: 10.1136/bmjopen-2024-088945.
5
Chronic Obstructive Pulmonary Disease Mortality and Hospitalization during the COVID-19 Pandemic Compared with before the Pandemic: A Systematic Review and Meta-Analysis.与大流行前相比,COVID-19大流行期间慢性阻塞性肺疾病的死亡率和住院率:一项系统评价和荟萃分析。
J Pers Med. 2024 Mar 10;14(3):296. doi: 10.3390/jpm14030296.
6
Chronic obstructive pulmonary disease trajectory: severe exacerbations and dynamic change in health-related quality of life.慢性阻塞性肺疾病轨迹:严重加重和健康相关生活质量的动态变化。
BMJ Open Respir Res. 2024 Feb 21;11(1):e002037. doi: 10.1136/bmjresp-2023-002037.
7
Early versus non-early desaturation during 6MWT in COPD patients: A follow-up study.慢性阻塞性肺疾病患者6分钟步行试验期间早期与非早期血氧饱和度降低的随访研究
Lung India. 2023 May-Jun;40(3):235-241. doi: 10.4103/lungindia.lungindia_404_22.
8
Comorbid Heart Disease in Patients with COPD is Associated with Increased Hospitalization and Mortality - A 15-Year Follow-Up.COPD 患者合并心脏病与住院和死亡风险增加相关 - 一项长达 15 年的随访研究。
Int J Chron Obstruct Pulmon Dis. 2023 Jan 9;18:11-21. doi: 10.2147/COPD.S378979. eCollection 2023.
9
Development and Validation of a Multivariable Prediction Model to Identify Acute Exacerbation of COPD and Its Severity for COPD Management in China (DETECT Study): A Multicenter, Observational, Cross-Sectional Study.开发和验证一种多变量预测模型,以识别中国 COPD 急性加重及其严重程度,用于 COPD 管理(DETECT 研究):一项多中心、观察性、横断面研究。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 5;17:2093-2106. doi: 10.2147/COPD.S363935. eCollection 2022.
10
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.慢性阻塞性肺疾病患者中重度加重的预后危险因素:系统文献回顾。
Respir Res. 2022 Aug 23;23(1):213. doi: 10.1186/s12931-022-02123-5.

本文引用的文献

1
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.美国胸科学会/欧洲呼吸学会官方声明:慢性阻塞性肺疾病的研究问题
Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315.
2
Systemic effects of inhaled corticosteroids: an overview.吸入性糖皮质激素的全身效应:综述
Open Respir Med J. 2014 Dec 31;8:59-65. doi: 10.2174/1874306401408010059. eCollection 2014.
3
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort.慢性阻塞性肺疾病(COPD)的住院加重:ECLIPSE队列中的危险因素及预后
Chest. 2015 Apr;147(4):999-1007. doi: 10.1378/chest.14-0655.
4
Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation.慢性阻塞性肺疾病急性加重期急诊科评估后两个月内住院的预测因素。
Respiration. 2014;88(4):298-306. doi: 10.1159/000365996. Epub 2014 Sep 10.
5
The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients.慢性阻塞性肺疾病急性加重的临床和经济影响:一组住院患者
PLoS One. 2014 Jun 27;9(6):e101228. doi: 10.1371/journal.pone.0101228. eCollection 2014.
6
Predictors of exacerbation frequency in chronic obstructive pulmonary disease.慢性阻塞性肺疾病恶化频率的预测因素。
Eur J Med Res. 2014 Apr 8;19(1):18. doi: 10.1186/2047-783X-19-18.
7
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.在 ECLIPSE 之后,我们是否应该对慢性阻塞性肺疾病有不同的看法?来自研究团队的临床观点。
Am J Respir Crit Care Med. 2014 May 1;189(9):1022-30. doi: 10.1164/rccm.201311-2006PP.
8
Spanish guideline for COPD (GesEPOC). Update 2014.西班牙慢性阻塞性肺疾病指南(GesEPOC)。2014年更新版。
Arch Bronconeumol. 2014 Jan;50 Suppl 1:1-16. doi: 10.1016/S0300-2896(14)70070-5.
9
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.慢性阻塞性肺疾病频繁加重表型的机制和影响。
BMC Med. 2013 Aug 14;11:181. doi: 10.1186/1741-7015-11-181.
10
Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study.因 COPD 急性加重住院患者的合并症与短期预后:EPOC en Servicios de medicina interna(ESMI)研究。
Chest. 2012 Nov;142(5):1126-1133. doi: 10.1378/chest.11-2413.

慢性阻塞性肺疾病住院加重和死亡的预测因素

Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.

作者信息

Santibáñez Miguel, Garrastazu Roberto, Ruiz-Nuñez Mario, Helguera Jose Manuel, Arenal Sandra, Bonnardeux Cristina, León Carlos, García-Rivero Juan Luis

机构信息

Preventive Medicine and Public Health Area, Universidad de Cantabria-IDIVAL, Santander, Cantabria, Spain.

Centro de Salud de Gama, Servicio Cántabro de Salud, Bárcena de Cicero, Cantabria, Spain.

出版信息

PLoS One. 2016 Jun 30;11(6):e0158727. doi: 10.1371/journal.pone.0158727. eCollection 2016.

DOI:10.1371/journal.pone.0158727
PMID:27362765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4928940/
Abstract

BACKGROUND AND AIM

Exacerbations of chronic obstructive pulmonary disease (COPD) carry significant consequences for patients and are responsible for considerable health-care costs-particularly if hospitalization is required. Despite the importance of hospitalized exacerbations, relatively little is known about their determinants. This study aimed to analyze predictors of hospitalized exacerbations and mortality in COPD patients.

METHODS

This was a retrospective population-based cohort study. We selected 900 patients with confirmed COPD aged ≥35 years by simple random sampling among all COPD patients in Cantabria (northern Spain) on December 31, 2011. We defined moderate exacerbations as events that led a care provider to prescribe antibiotics or corticosteroids and severe exacerbations as exacerbations requiring hospital admission. We observed exacerbation frequency over the previous year (2011) and following year (2012). We categorized patients according to COPD severity based on forced expiratory volume in 1 second (Global Initiative for Chronic Obstructive Lung Disease [GOLD] grades 1-4). We estimated the odds ratios (ORs) by logistic regression, adjusting for age, sex, smoking status, COPD severity, and frequent exacerbator phenotype the previous year.

RESULTS

Of the patients, 16.4% had ≥1 severe exacerbations, varying from 9.3% in mild GOLD grade 1 to 44% in very severe COPD patients. A history of at least two prior severe exacerbations was positively associated with new severe exacerbations (adjusted OR, 6.73; 95% confidence interval [CI], 3.53-12.83) and mortality (adjusted OR, 7.63; 95%CI, 3.41-17.05). Older age and several comorbidities, such as heart failure and diabetes, were similarly associated.

CONCLUSIONS

Hospitalized exacerbations occurred with all grades of airflow limitation. A history of severe exacerbations was associated with new hospitalized exacerbations and mortality.

摘要

背景与目的

慢性阻塞性肺疾病(COPD)急性加重对患者具有重大影响,且导致可观的医疗费用,尤其是在需要住院治疗的情况下。尽管住院急性加重很重要,但对其决定因素的了解相对较少。本研究旨在分析COPD患者住院急性加重和死亡的预测因素。

方法

这是一项基于人群的回顾性队列研究。2011年12月31日,我们通过简单随机抽样在坎塔布里亚(西班牙北部)的所有COPD患者中选取了900例确诊的≥35岁的COPD患者。我们将中度急性加重定义为导致医护人员开具抗生素或皮质类固醇的事件,将重度急性加重定义为需要住院治疗的急性加重。我们观察了前一年(2011年)和次年(2012年)的急性加重频率。我们根据基于1秒用力呼气量的COPD严重程度对患者进行分类(慢性阻塞性肺疾病全球倡议[GOLD]1-4级)。我们通过逻辑回归估计比值比(OR),并对年龄、性别、吸烟状况、COPD严重程度和前一年的频繁急性加重表型进行校正。

结果

在这些患者中,16.4%发生了≥1次重度急性加重,从轻度GOLD 1级的9.3%到极重度COPD患者的44%不等。至少有两次既往重度急性加重史与新的重度急性加重(校正OR,6.73;95%置信区间[CI],3.53-12.83)和死亡率(校正OR,7.63;95%CI,3.41-17.05)呈正相关。年龄较大以及合并几种疾病,如心力衰竭和糖尿病,也有类似的相关性。

结论

所有级别的气流受限都会发生住院急性加重。重度急性加重史与新的住院急性加重和死亡率相关。